Skip to main content

Advertisement

SpringerLink
Log in

Management of Locoregional and Systemic Recurrence of Breast Cancer: To Stage or Not to Stage and How

  • Breast Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

The surveillance of breast cancer patients after potentially curative treatment may result in the identification of locoregional or distant recurrence. While many patients expect frequent imaging studies to monitor for recurrence, there are no data supporting aggressive imaging surveillance beyond mammography. However, when recurrent disease is suspected, it is appropriate to undertake re-staging to develop a rational management plan. The rationale and methods for appropriate surveillance and re-staging are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Loprinzi C. Follow-up care after breast cancer treatment. Mayo Clin Womens Healthsource. 2004;8:suppl 1–2.

    Google Scholar 

  2. de Bock GH, Bonnema J, Zwaan RE, van de Velde CJ, Kievit J, Stiggelbout AM. Patient’s needs and preferences in routine follow-up after treatment for breast cancer. Br J Cancer. 2004;90:1144–50.

    Article  PubMed  Google Scholar 

  3. Hess KR, Esteva FJ. Effect of HER2 status on distant recurrence in early stage breast cancer. Breast Cancer Res Treat. 2013;137:449–55.

    Article  PubMed  CAS  Google Scholar 

  4. Early Breast Cancer Trialists’ Collaborative G, Darby S, McGale P, Correa C, Taylor C, Arriagada R, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378:1707–16.

    Article  PubMed  CAS  Google Scholar 

  5. Veronesi U, Marubini E, Del Vecchio M, Manzari A, Andreola S, Greco M, et al. Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. J Natl Cancer Inst. 1995;87:19–27.

    Article  PubMed  CAS  Google Scholar 

  6. Wapnir IL, Anderson SJ, Mamounas EP, Geyer CE Jr, Jeong JH, Tan-Chiu E, et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials. J Clin Oncol. 2006;24:2028–37.

    Article  PubMed  Google Scholar 

  7. Anderson SJ, Wapnir I, Dignam JJ, Fisher B, Mamounas EP, Jeong JH, et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer. J Clin Oncol. 2009;27:2466–73.

    Article  PubMed  Google Scholar 

  8. Janni W, Dimpfl T, Braun S, Knobbe A, Peschers U, Rjosk D, et al. Radiotherapy of the chest wall following mastectomy for early-stage breast cancer: impact on local recurrence and overall survival. Int J Radiat Oncol Biol Phys. 2000;48:967–75.

    Article  PubMed  CAS  Google Scholar 

  9. Halyard MY, Wasif N, Harris EE, Arthur DW, Bailey L, Bellon JR, et al. ACR Appropriateness Criteria(R) local-regional recurrence (LR) and salvage surgery: breast cancer. Am J Clin Oncol. 2012;35:178–82.

    Article  PubMed  Google Scholar 

  10. Schmoor C, Sauerbrei W, Bastert G, Schumacher M. Role of isolated locoregional recurrence of breast cancer: results of four prospective studies. J Clin Oncol. 2000;18:1696–708.

    PubMed  CAS  Google Scholar 

  11. Khatcheressian JL, Hurley P, Bantug E, Esserman LJ, Grunfeld E, Halberg F, et al. Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31:961–5.

    Article  PubMed  CAS  Google Scholar 

  12. Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Breast Cancer V.3.2013. © National Comprehensive Cancer Network, Inc 2013. All rights reserved. NATIONAL COMPREHENSIVE CANCER NETWORK®, NCCN®, NCCN GUIDELINES®, and all other NCCN Content are trademarks owned by the National Comprehensive Cancer Network, Inc. www.nccn.org.

  13. Palli D, Russo A, Saieva C et al. Intensive vs clinical follow-up after treatment of primary breast cancer: 10-year update of a randomized trial. National Research Council Project on Breast Cancer Follow-up. JAMA. 1999;281:1586.

    Article  PubMed  CAS  Google Scholar 

  14. Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. The GIVIO Investigators. JAMA. 1994;271:1587–92.

  15. Chlebowski RT, Geller ML. Adherence to endocrine therapy for breast cancer. Oncology. 2006;71:1–9.

    PubMed  CAS  Google Scholar 

  16. Barron TI, Connolly R, Bennett K, Feely J, Kennedy MJ. Early discontinuation of tamoxifen: a lesson for oncologists. Cancer. 2007;109:832–9.

    Article  PubMed  CAS  Google Scholar 

  17. Rena O, Papalia E, Ruffini E, Filosso PL, Oliaro A, Maggi G, et al. The role of surgery in the management of solitary pulmonary nodule in breast cancer patients. Eur J Surg Oncol. 2007;33:546–50.

    Article  PubMed  CAS  Google Scholar 

  18. Abbott DE, Brouquet A, Mittendorf EA, Andreou A, Meric-Bernstam F, Valero V, et al. Resection of liver metastases from breast cancer: estrogen receptor status and response to chemotherapy before metastasectomy define outcome. Surgery. 2012;151:710–6.

    Article  PubMed  Google Scholar 

  19. Costelloe CM, Rohren EM, Madewell JE, Hamaoka T, Theriault RL, Yu TK, et al. Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis. Lancet Oncol. 2009;10:606–14.

    Article  PubMed  Google Scholar 

Download references

Disclosures

No financial disclosures

Author information

Authors and Affiliations

  1. Division of Surgical Oncology, UT Southwestern Medical Center, Dallas, TX, USA

    A. Marilyn Leitch MD

Authors
  1. A. Marilyn Leitch MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Marilyn Leitch MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leitch, A.M. Management of Locoregional and Systemic Recurrence of Breast Cancer: To Stage or Not to Stage and How. Ann Surg Oncol 20, 3194–3198 (2013). https://doi.org/10.1245/s10434-013-3180-6

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-013-3180-6

Keywords

Search

Navigation